Evaluation of Skeletal Maturity for Slipped Capital Femoral Epiphysis

ClinicalTrials.gov ID: NCT01220882

Public ClinicalTrials.gov record NCT01220882. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 11, 2026, 7:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Skeletal Age Assessment From the Olecranon For Slipped Capital Femoral Epiphysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being done for two reasons: 1) to evaluate growth problems in the hip in patients with Slipped Capital Femoral Epiphysis (SCFE) as they continue to grow into adults, and 2) to help doctors determine which patients are at risk for developing a SCFE on their opposite hip. Studies show that up to 60% of patients with a SCFE will go on to develop a SCFE on their other side. Being able to better determine which patients are at risk for developing a SCFE on the other side will help physicians better monitor patients with a history of a SCFE and perhaps treat them before they develop a SCFE on the opposite side. By studying the growth centers seen on X-rays of your child's legs and elbow, the investigators may be able to better predict which children with a SCFE are at risk for developing a SCFE on their opposite hip and potential growth problems as they continue to grow.

Study identification

NCT ID: NCT01220882
Recruitment status: Not listed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Rutgers, The State University of New Jersey; Other
Enrollment: 60 participants

Conditions and interventions

Conditions

Slipped Capital Femoral Epiphysis

Interventions

Radiographic skeletal age assessment Radiation

Radiation

Eligibility (public fields only)

Age range: 8 Years to 16 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2008
Primary completion: Jun 30, 2015
Completion: Nov 30, 2015
Last update posted: Dec 24, 2013

2008 – 2015

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of Medicine and Dentistry of New Jersey	Newark	New Jersey	07101	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01220882, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 24, 2013 · Synced Sep 11, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01220882 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →